CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -60.0% | 200 | 0.0% | 0.00% | – |
| Q2 2015 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q4 2013 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | +133.3% | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q1 2013 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2012 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2012 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2012 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2012 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q4 2011 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2011 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2011 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2011 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2010 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |